ArticleLeukemia & lymphoma2016

STAT3 inhibitor has potent antitumor activity in B-lineage acute lymphoblastic leukemia cells overexpressing the high mobility group A1 (HMGA1)-STAT3 pathway.

Amy Belton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.